We recently reported that genetic depletion of MK2 within the myeloid compartment—neutrophils, dendritic cells, macrophages, etc.—reduced inflammatory colon tumor progression and impaired tumor neo-angiogenesis. This evidence concerns the gene MAPKAPK2 and colonic neoplasm.